# Transdermally Delivered Human Insulin Product

> **NCT03544996** · — · COMPLETED · sponsor: **Transdermal Delivery Solutions Corp** · enrollment: 1 (actual)

## Conditions studied

- Hypoinsulinemia

## Interventions

- **COMBINATION_PRODUCT:** TD Insulin

## Key facts

- **NCT ID:** NCT03544996
- **Lead sponsor:** Transdermal Delivery Solutions Corp
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-09
- **Primary completion:** 2018-02-04
- **Final completion:** 2018-02-04
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2018-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03544996

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03544996, "Transdermally Delivered Human Insulin Product". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03544996. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*